人源尿液基质质控品，包含多种滥用药物组合，可检测高于或低于阿片类药物临界值为 2000 ng/mL 确认临界水平 20–25% 浓度的标本
描述
Liquichek 尿液毒性质控品，C2 & 和 C3 水平，人源尿液基质，含有浓度高于或低于新的 SAMHSA 确认性临界水平 20–~25% 的额外滥用药物 或其代谢物 。
- 2–~8°C 下的保质期为 3 年
- 2–~8°C 下的开瓶后稳定期为 30 天
- 2,000 ng/mL Opiate 临界值
有关当前分析物声明，请参考药品说明书。
重量参考值
| 分析物 | Level C1 (ng/mL) |
Level C2 Low Opiate (ng/mL) |
Level C3 Low Opiate (ng/mL) |
Level C2 (ng/mL) |
Level C3 (ng/mL) |
Level C4 (ng/mL) |
| 货号 | 441 | 468 | 469 | 442 | 443 | 444 |
| Amphetamines d-Amphetamine d-Methamphetamine 3, 4-Methylenedioxymethamphetamine (MDMA) 3, 4-Methylenedioxyamphetamine (MDA) 3, 4-Methylenedioxy-N-ethylamphetamine (MDEA) |
100 100 100 100 100 |
375 375 — — — |
625 625 — — — |
375 375 188 188 188 |
625 625 312 312 312 |
1,500 1,500 750 750 750 |
| Barbiturates Amobarbitital Butalbital Pentobarbital Phenobarbitital Secobarbital |
80 80 80 80 80 |
150 150 150 150 150 |
250 250 250 250 250 |
150 150 150 150 150 |
250 250 250 250 250 |
1,200 1,200 1,200 1,200 1,200 |
| Benzodiazepines α-Hydroxyalprazolam Nordiazepam Oxazepam* |
80 80 * |
225 225 * |
375 375 * |
225 225 * |
375 375 * |
1,000 1,000 * |
| Cannabinoids 11-Nor-Δ-9-THC-9-COOH |
6 | 11.5 | 18.5 | 11.5 | 18.5 | 150 |
| Cocaine Benzoylecgonine |
40 | 115 | 185 | 115 | 185 | 1,000 |
| 乙醇 (mg/dL) | 20 | 40 | 70 | 40 | 70 | 250 |
| 麦角酸二乙基酰胺 (LSD) | 0.2 | 0.35 | 0.65 | 0.35 | 0.65 | 4.0 |
| Methadone Methadone EDDP (Methadone Metabolite)* |
120 * |
225 * |
375 * |
225 * |
375 * |
1,000 * |
| 安眠酮 | 120 | 225 | 375 | 225 | 375 | 1,000 |
| Opiates 6-Monoacetylmorphine* Codeine Morphine-3-β-d-Glucuronide |
* 120 120 |
* 225 225 |
* 375 375 |
* 1,500 1,500 |
* 2,500 2,500 |
* 4,000 4,000 |
| 苯环己哌啶 (PCP) | 10 | 19 | 31 | 19 | 31 | 100 |
| Propoxyphenes Propoxyphene Norpropoxyphene |
120 120 |
225 225 |
375 375 |
225 225 |
375 375 |
1,000 1,000 |
* 存在分析物，没有关于性能或稳定性方面的声明。
订购
items
Use the filters below to refine results!
(停产) Liquichek Urine Toxicology Control, Level C2
442
Liquid human urine confirmatory control with drugs of abuse at 20–25% below confirmatory cutoff levels; for 2,000 ng/mL Opiate cutoff (10 x 20 mL)
(停产) Liquichek Urine Toxicology Control, Level C3
443
Liquid human urine confirmatory control with drugs of abuse at 20–25% above confirmatory cutoff levels; for 2,000 ng/mL Opiate cutoff (10 x 20 mL)
(停产) Liquichek Urine Toxicology Control, Level C2 MiniPak
442X
Liquid human urine confirmatory control with drugs of abuse at 20–25% below confirmatory cutoff levels; for 2,000 ng/mL Opiate cutoff (1 x 20 mL)
(停产) Liquichek Urine Toxicology Control, Level C3 MiniPak
443X
Liquid human urine confirmatory control with drugs of abuse at 20–25% above confirmatory cutoff levels; for 2,000 ng/mL Opiate cutoff (1 x 20 mL)
(停产) Liquichek Urine Toxicology Negative Control
460
Liquid human urine negative control confirmed negative at the specified detection limits for over 30 drugs of abuse (10 x 20 mL)
(停产) Liquichek Urine Toxicology Negative Control, MiniPak
460X
Liquid human urine negative control confirmed negative at the specified detection limits for over 30 drugs of abuse; MiniPak (1 x 20 mL)
配套设备
(停产) Dispenser Tips for Crimp Seals
588
Disposable plastic tip accessory to enable fluid delivery directly from glass vials supplied with a metal crimp seal and stopper. 50/Package